This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Varicose Veins
and you are
between 18 and 75
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

To determine the effect and safety of Varisolve® 0.125% [0.2%]

Provided treatments

  • Drug: Polidocanol Endovenous Microfoam 0.125%
Tris trial is registered with FDA with number: NCT00928421. The sponsor of the trial is BTG International Inc. and it is looking for 16 volunteers for the current phase.
Official trial title:
An Open-label, Single-dose Pilot Study to Evaluate the Efficacy and Safety of Varisolve® (Polidocanol Endovenous Microfoam) 0.125% [0.2%] for the Treatment of Symptomatic, Visible Varicose Veins With Saphenofemoral Junction (SFJ) Incompetence